Arthrosamid or ChondroFiller: what is the difference?

Start with the clinical problem

These names are often compared as though they were interchangeable injections. They are different materials, used with different treatment aims. The useful starting point is whether the discussion concerns osteoarthritis symptoms, a cartilage lesion or a more complex joint problem.

Arthrosamid: a hydrogel approach

Arthrosamid is a non-absorbable polyacrylamide hydrogel used for knee osteoarthritis symptoms. Its role should not be described as growing replacement cartilage. A change in pain is valuable, but does not on its own demonstrate structural repair.

• [1] Arthrosamid instructions for use, October 2025

ChondroFiller: a collagen scaffold approach

ChondroFiller is a cell-free type I collagen matrix designed to fill a cartilage defect. The manufacturer describes preparation of the defect followed by arthroscopic or minimally open implantation; the liquid sets into a scaffold at the target site.

That manufacturer-described procedure is distinct from a general joint injection. If a different delivery technique is proposed, ask what evidence applies to that exact technique and your type of cartilage damage.

• [2] Meidrix: ChondroFiller material and implantation technique

Compare plans, not just products

Compare the expected benefit, uncertainty, aftercare, total cost and alternatives in your own case. AMSK’s published Arthrosamid packages describe its current care offer; discussion of ChondroFiller here is educational and does not create a new AMSK treatment package.